High-mobility group box 1 inhibits gastric ulcer healing through toll-like receptor 4 and receptor for advanced glycation end products

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Nadatani, Yuji ^a   Watanabe, Toshio ^a   Tanigawa, Tetsuya ^a   Ohkawa, Fumikazu ^b   Takeda, Shogo ^a   Higashimori, Akira ^a   Sogawa, Mitsue ^a   Yamagami, Hirokazu ^a   Shiba, Masatsugu ^a   Watanabe, Kenji ^a   Tominaga, Kazunari ^a   Fujiwara, Yasuhiro ^a   Takeuchi, Koji ^b   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ADVANCED GLYCATION END PRODUCT RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; MYELOPEROXIDASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STOMACH ULCER; ULCER HEALING; UPREGULATION; WILD TYPE;

ACETIC ACID; ANIMALS; ANTIBODIES; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HMGB1 PROTEIN; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; PEROXIDASE; RECEPTORS, IMMUNOLOGIC; RECOVERY OF FUNCTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STOMACH; STOMACH ULCER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893199488     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080130     Document Type: Article

References (58)

1. Bustin M (1999) Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 19: 5237-5246. PubMed: 10409715.
2. Park JS, Arcaroli J, Yum HK, Yang H, Wang H et al. (2003) Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 284: C870-C879. doi:10.1152/ajpcell.00322.2002. PubMed: 12620891. (Pubitemid 36336943)
3. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195. doi:10.1038/nature00858. PubMed: 12110890. (Pubitemid 34773774)
4. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O et al. (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192: 565-570. doi:10.1084/jem.192.4.565. PubMed: 10952726. (Pubitemid 30666257)
5. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251. doi:10.1126/science.285.5425.248. PubMed: 10398600. (Pubitemid 29329996)
6. Yu M, Wang H, Ding A, Golenbock DT, Latz E et al. (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26: 174-179. doi:10.1097/01.shk.0000225404.51320.82. PubMed: 16878026. (Pubitemid 44162504)
7. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY et al. (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290: C917-C924. PubMed: 16267105.
8. van Zoelen MA, Yang H, Florquin S, Meijers JC, Akira S et al. (2009) Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 31: 280-284. doi:10.1097/SHK. 0b013e318186262d. PubMed: 19218854.
9. Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V et al. (2003) Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J Immunol 170: 508-519. PubMed: 12496438. (Pubitemid 36026178)
10. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T et al. (1999) Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752. PubMed: 10201887. (Pubitemid 29314747)
11. Qin YH, Dai SM, Tang GS, Zhang J, Ren D et al. (2009) HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J Immunol 183: 6244-6250. doi: 10.4049/jimmunol.0900390. PubMed: 19890065.
12. Watanabe T, Higuchi K, Kobata A, Nishio H, Tanigawa T et al. (2008) Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 57: 181-187. doi:10.1136/gut. 2007.125963. PubMed: 17639086.
13. Watanabe T, Nishio H, Tanigawa T, Yamagami H, Okazaki H et al. (2009) Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. Am J Physiol Gastrointest Liver Physiol 297: G506-G513. doi:10.1152/ajpgi.90553.2008. PubMed: 19589943.
14. Herold K, Moser B, Chen Y, Zeng S, Yan SF et al. (2007) Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J Leukoc Biol 82: 204-212. doi:10.1189/jlb.1206751. PubMed: 17513693. (Pubitemid 47230628)
15. Yan SD, Chen X, Fu J, Chen M, Zhu H et al. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691. doi:10.1038/382685a0. PubMed: 8751438. (Pubitemid 26282167)
16. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R et al. (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275: 40096-40105. doi:10.1074/jbc.M006993200. PubMed: 11007787. (Pubitemid 32064635)
17. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA et al. (1997) Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810-17814. doi:10.1074/jbc.272.28.17810. PubMed: 9211935. (Pubitemid 27311222)
18. Marsche G, Semlitsch M, Hammer A, Frank S, Weigle B et al. (2007) Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway. FASEB J 21: 1145-1152. doi:10.1096/fj.06-7439com.PubMed: 17218539.
19. Zeng S, Dun H, Ippagunta N, Rosario R, Zhang QY et al. (2009) Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. J Hepatol 50: 929-936. doi:10.1002/hep.23104. PubMed: 19303658.
20. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC et al. (2000) Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360. doi:10.1038/35012626. PubMed: 10830965. (Pubitemid 30337069)
21. Huang W, Tang Y, Li L (2010) HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 51: 119-126. doi:10.1016/j.cyto.2010.02.021. PubMed: 20347329.
22. Sawa H, Ueda T, Takeyama Y, Yasuda T, Shinzeki M et al. (2006) Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J Gastroenterol 12: 7666-7670. PubMed: 17171797. (Pubitemid 46040580)
23. Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F et al. (2005) HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 288: L958-L965. doi:10.1152/ajplung.00359.2004. PubMed: 15640285. (Pubitemid 40547924)
24. Urbonaviciute V, Voll RE (2011) High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus. J Intern Med 270: 309-318. doi: 10.1111/j.1365-2796.2011. 02432.x. PubMed: 21793951.
25. Qiu J, Xu J, Zheng Y, Wei Y, Zhu X et al. (2010) High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke 41: 2077-2082. doi:10.1161/STROKEAHA.110.590463. PubMed: 20671243.
26. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP et al. (2005) The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201: 1135-1143. doi:10.1084/jem.20042614. PubMed: 15795240. (Pubitemid 40524681)
27. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN et al. (2008) High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117: 3216-3226. doi:10.1161/CIRCULATIONAHA. 108.769331. PubMed: 18574060.
28. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P et al. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859. doi:10.1172/JCI31008. PubMed: 17853945. (Pubitemid 47529615)
29. Maeda S, Hikiba Y, Shibata W, Ohmae T, Yanai A et al. (2007) Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer. Biochem Biophys Res Commun 360: 394-400. doi:10.1016/j.bbrc.2007.06.065. PubMed: 17599806. (Pubitemid 47030357)
30. Davé SH, Tilstra JS, Matsuoka K, Li F, DeMarco RA et al. (2009) Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. J Leukoc Biol 86: 633-643. doi:10.1189/jlb.1008662. PubMed: 19454652.
31. Nadatani Y, Watanabe T, Tanigawa T, Machida H, Okazaki H et al. (2012) High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4. Am J Pathol 181: 98-110. doi:10.1016/j.ajpath.2012.03.039. PubMed: 22634181.
32. Okabe S, Roth JL, Pfeiffer CJ (1971) A method for experimental, penetrating gastric and duodenal ulcers in rats. Observations on normal healing. Am J Dig Dis 16: 277-284. doi:10.1007/BF02235252. PubMed: 5554507.
33. Tanigawa T, Watanabe T, Otani K, Nadatani Y, Machida H et al. (2010) Leptin promotes gastric ulcer healing via upregulation of vascular endothelial growth factor. Digestion 81: 86-95. doi:10.1159/000243719. PubMed: 20068308.
34. Watanabe T, Arakawa T, Fukuda T, Higuchi K, Kobayashi K (1995) Zinc deficiency delays gastric ulcer healing in rats. Dig Dis Sci 40:1340-1344. doi:10.1007/BF02065548. PubMed: 7781457.
35. Watanabe T, Kobata A, Tanigawa T, Nadatani Y, Yamagami H et al. (2012) Activation of the MyD88 signaling pathway inhibits ischemiareperfusion injury in the small intestine. Am J Physiol Gastrointest Liver Physiol 303: G324-G334. doi:10.1152/ajpgi.00075.2012. PubMed: 22628037.
36. Otani K, Tanigawa T, Watanabe T, Nadatani Y, Sogawa M et al. (2012) Toll-like receptor 9 signaling has anti-inflammatory effects on the early phase of Helicobacter pylori-induced gastritis. Biochem Biophys Res Commun 426: 342-349. doi:10.1016/j.bbrc.2012.08.080. PubMed: 22940550.
37. Zhang Q, O'Hearn S, Kavalukas SL, Barbul A (2012) Role of high mobility group box 1 (HMGB1) in wound healing. J Surg Res 176: 343-347. doi:10.1016/j.jss.2011.06.069. PubMed: 21872885.
38. Goova MT, Li J, Kislinger T, Qu W, Lu Y et al. (2001) Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159: 513-525. doi:10.1016/S0002-9440(10)61723-3. PubMed: 11485910. (Pubitemid 32751082)
39. Straino S, Di Carlo A, Mangoni A, De Mori R, Guerra L et al. (2008) High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol 128: 1545-1553. doi: 10.1038/sj.jid.5701212. PubMed: 18239618. (Pubitemid 351693201)
40. Ranzato E, Patrone M, Pedrazzi M, Burlando B (2010) Hmgb1 promotes wound healing of 3T3 mouse fibroblasts via RAGEdependent ERK1/2 activation. Cell Biochem Biophys 57: 9-17. doi:10.1007/s12013-010-9077-0. PubMed: 20361273.
41. Shimizu N, Watanabe T, Arakawa T, Fujiwara Y, Higuchi K et al. (2000) Pentoxifylline accelerates gastric ulcer healing in rats: roles of tumor necrosis factor alpha and neutrophils during the early phase of ulcer healing. Digestion 61: 157-164. doi:10.1159/000007752. PubMed: 10773720. (Pubitemid 30199365)
42. Goren I, Müller E, Schiefelbein D, Christen U, Pfeilschifter J et al. (2007) Systemic anti-TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 127: 2259-2267. doi:10.1038/sj.jid.5700842. PubMed: 17460730. (Pubitemid 47258485)
43. Suzuki N, Takahashi S, Okabe S (1998) Relationship between vascular endothelial growth factor and angiogenesis in spontaneous and indomethacin-delayed healing of acetic acid-induced gastric ulcers in rats. J Physiol Pharmacol 49: 515-527. PubMed: 10069693. (Pubitemid 29024370)
44. Takahashi M, Kawabe T, Ogura K, Maeda S, Mikami Y et al. (1997) Expression of vascular endothelial growth factor at the human gastric ulcer margin and in cultured gastric fibroblasts: a new angiogenic factor for gastric ulcer healing. Biochem Biophys Res Commun 234: 493-498. doi:10.1006/bbrc.1997. 5974. PubMed: 9177300. (Pubitemid 27243932)
45. Biscetti F, Straface G, De Cristofaro R, Lancellotti S, Rizzo P et al. (2010) High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism. Diabetes 59: 1496-1505. doi:10.2337/db09-1507. PubMed: 20200317.
46. Rossini A, Zacheo A, Mocini D, Totta P, Facchiano A et al. (2008) HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J Mol Cell Cardiol 44: 683-693. doi:10.1016/j.yjmcc.2008.01.009. PubMed: 18328501.
47. Lei C, Lin S, Zhang C, Tao W, Dong W et al. (2013) Effects of high-mobility group box1 on cerebral angiogenesis and neurogenesis after intracerebral hemorrhage. Neuroscience 229: 12-19. doi:10.1016/j.neuroscience. 2012.10.054. PubMed: 23137544.
48. Degryse B, Bonaldi T, Scaffidi P, Müller S, Resnati M et al. (2001) The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 152: 1197-1206. doi:10.1083/jcb.152.6.1197. PubMed: 11257120. (Pubitemid 34280177)
49. Nagato M, Okamoto K, Abe Y, Higure A, Yamaguchi K (2009) Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia. Crit Care Med 37: 2181-2186. doi:10.1097/CCM. 0b013e3181a55184. PubMed: 19487933.
50. Esmon C (2005) Do-all receptor takes on coagulation, inflammation. Nat Med 11: 475-477. doi:10.1038/nm0505-475. PubMed: 15875050.
51. Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y et al. (2005) The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest 115: 1267-1274. doi:10.1172/JCI200522782. PubMed: 15841214. (Pubitemid 40629045)
52. Inoue Y, Saito T, Ogawa K, Nishio Y, Kosugi S et al. (2013) Role of serum high mobility group box 1 in hematological malignancies complicated with systemic inflammatory response syndrome and effect of recombinant thrombomodulin. Leuk: Lymphoma.
53. Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M et al. (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113: 1641-1650. doi:10.1172/ JCI200418704. PubMed: 15173891. (Pubitemid 39071688)
54. Watanabe T, Higuchi K, Hamaguchi M, Tanigawa T, Wada R et al. (2002) Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils. Dig Dis Sci 47: 1582-1589. doi:10.1023/A:1015879421739. PubMed: 12141820. (Pubitemid 34753939)
55. Shimizu T, Kusugami K, Ina K, Imada A, Nishio Y et al. (2000) Helicobacter pylori-associated gastric ulcer exhibits enhanced mucosal chemokine activity at the ulcer site. Digestion 62: 87-94. doi:10.1159/000007800. PubMed: 11025355.
56. Radin JN, González-Rivera C, Ivie SE, McClain MS, Cover TL (2011) Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells. Infect Immun 79: 2535-2543. doi:10.1128/IAI.01370-10. PubMed: 21482684.
57. Zeng S, Feirt N, Goldstein M, Guarrera J, Ippagunta N et al. (2004) Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 39: 422-432. doi:10.1002/hep.20045. PubMed: 14767995. (Pubitemid 38222183)
58. Susa Y, Masuda Y, Imaizumi H, Namiki A (2009) Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis. Crit Care Med 37: 2619-2624. doi:10.1097/CCM.0b013e3181a930f7. PubMed: 19623040.